ATA, formerly anti-Scl70 antibodies, are present in 3–75% of patients with SSc, with a sensitivity of 34%, which increases to 40% in patients with diffuse cutaneous SSc (3, 4). The gene discussed is ATM; the disease is systemic sclerosis.